Risk factors for anti-tuberculosis treatment failure

E. Lesnic, V. Zlepca (Chisinau, Republic Of Moldova)

Source: Annual Congress 2011 - Tuberculosis epidemiology and public health

Session: Tuberculosis epidemiology and public health
Session type: Thematic Poster Session
Number: 2639

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Lesnic, V. Zlepca (Chisinau, Republic Of Moldova). Risk factors for anti-tuberculosis treatment failure. Eur Respir J 2011; 38: Suppl. 55, 2639

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Predictive factors for antituberculosis treatment failure Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Risk factors of hepatotoxicity during tuberculosis treatment and management Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Refractory asthma and risk factors for treatment failure Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005
Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization. Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Risk factors for relapses of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Risk factors of development of amplified Mtb resistance to antituberculous drugs Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Risk factors for anti-TB drug resistance in Poland Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
Scleroderma lung disease: Risk factors and treatment options Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Risk factors for paradoxical response during adequate tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Risk factors in tuberculosis and its influence on chemotherapy efficiency Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Risk factors for asthma and their prevention Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management Year: 2008
The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006
The risk factors of the TB death among case of initial treatment failure and retreatment after default Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021
Risk factors for failure in pulmonary TB new cases-10 years review Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010